EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD
Status:
RECRUITING
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
Iron deficiency anaemia (IDA) is common in inflammatory bowel disease (IBD). However, although iron is commonly prescribed, the amount of elemental iron needed to achieve clinical efficacy, and the optimal method of supplementation, are under debate. This pilot study aims to investigate the efficacy and safety of low dose and standard dose oral iron preparations for the treatment of IDA in patients with IBD.
Phase:
PHASE3
Details
Lead Sponsor:
Liverpool University Hospitals NHS Foundation Trust